Novartis AG Website

Novartis AG

SWX-NOVN

Basic

  • Market Cap

    CHF 196.24B

  • EV

    CHF 214.87B

  • Shares Out

    2,024.58M

  • Revenue

    $48.86B

  • Employees

    76,057

Margins

  • Gross

    75.55%

  • EBITDA

    40.21%

  • Operating

    30.97%

  • Pre-Tax

    22.31%

  • Net

    33.1%

  • FCF

    28.47%

Returns (5Yr Avg)

  • ROA

    10.54%

  • ROTA

    54.71%

  • ROE

    22.87%

  • ROCE

    13.54%

  • ROIC

    9.26%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    CHF 101.56

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $8,431M

  • Net Debt

    $20.56B

  • Debt/Equity

    0.69

  • EBIT/Interest

    16.7

Growth (CAGR)

  • Rev 3Yr

    -1.77%

  • Rev 5Yr

    0.88%

  • Rev 10Yr

    -0.91%

  • Dil EPS 3Yr

    25.68%

  • Dil EPS 5Yr

    9.99%

  • Dil EPS 10Yr

    7.14%

  • Rev Fwd 2Yr

    6.52%

  • EBITDA Fwd 2Yr

    8.07%

  • EPS Fwd 2Yr

    11.9%

  • EPS LT Growth Est

    8.82%

Dividends

  • Yield

    —

  • Payout

    79.57%

  • DPS

    $3.92

  • DPS Growth 3Yr

    4.94%

  • DPS Growth 5Yr

    6.65%

  • DPS Growth 10Yr

    3.6%

  • DPS Growth Fwd 2Yr

    0.76%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Operating Revenues

47,498

48,659

42,781

42,206

45,440

47,546

Other Revenues, Total

1,179

1,239

1,193

1,255

1,220

1,314

Total Revenues

48,677

49,898

43,974

43,461

46,660

48,860

Total Revenues % Chg.

5.6%

2.5%

-11.9%

-1.2%

7.4%

9.7%

Cost of Goods Sold, Total

14,425

15,121

11,391

11,297

12,020

11,947

Gross Profit

34,252

34,777

32,583

32,164

34,640

36,913

Selling General & Admin Expenses, Total

14,369

14,197

12,756

12,143

12,489

12,437

R&D Expenses

9,402

8,980

8,259

8,425

9,011

8,689

Other Operating Expenses

1,395

1,448

605

387

498

655

Other Operating Expenses, Total

25,166

24,625

21,620

20,955

21,998

21,781

Operating Income

9,086

10,152

10,963

11,209

12,642

15,132

Interest Expense, Total

-850

-869

-787

-800

-855

-906

Interest And Investment Income

245

91

70

377

627

627

Net Interest Expenses

-605

-778

-717

-423

-228

-279

Income (Loss) On Equity Invest.

659

673

15,337

-11

-13

-40

Currency Exchange Gains (Loss)

-160

-135

-69

-184

-214

-214

Other Non Operating Income (Expenses)

-40

-34

-39

-53

17

-166

EBT, Excl. Unusual Items

8,940

9,878

25,475

10,538

12,204

14,433

Restructuring Charges

—

—

—

—

—

-827

-1,822

-951

-951

Gain (Loss) On Sale Of Investments

—

—

—

—

38

-260

-105

-105

Gain (Loss) On Sale Of Assets

—

—

—

—

—

724

166

225

225

Asset Writedown

—

—

—

—

—

-619

-1,664

-3,088

-3,288

Legal Settlements

—

—

—

—

—

-170

-313

542

542

Other Unusual Items

—

—

—

-91

532

296

43

EBT, Incl. Unusual Items

8,940

9,878

24,530

7,177

9,123

10,899

Income Tax Expense

1,793

1,807

1,625

1,128

551

814

Earnings From Continuing Operations

7,147

8,071

22,905

6,049

8,572

10,085

Earnings Of Discontinued Operations

—

4,590

—

1,113

906

6,282

6,092

Minority Interest

—

-5

1

3

—

-4

-2

Net Income

11,732

8,072

24,021

6,955

14,850

16,175

Net Income to Common Incl Extra Items

11,732

8,072

24,021

6,955

14,850

16,175

Net Income to Common Excl. Extra Items

7,142

8,072

22,908

6,049

8,568

10,083

Total Shares Outstanding

2,265

2,256.8

2,234.9

2,119.6

2,044

2,024.6

Weighted Avg. Shares Outstanding

2,290.8

2,277

2,242.6

2,181.2

2,076.8

2,047.3

Weighted Avg. Shares Outstanding Dil

2,319

2,296

2,260

2,197

2,092

2,063.5

EPS

5.1

3.5

10.7

3.2

7.2

7.9

EPS Diluted

5.1

3.5

10.6

3.2

7.1

7.8

EBITDA

13,267

14,932

15,633

15,936

17,518

19,648

Effective Tax Rate

20.1%

18.3%

6.6%

15.7%

6%

7.5%